Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbial metabolites as multi-kingdom intermediates
Kimberly A. Krautkramer, Jing Fan, Fredrik Bäckhed
Nature Reviews Microbiology (2020) Vol. 19, Iss. 2, pp. 77-94
Closed Access | Times Cited: 889

Showing 1-25 of 889 citing articles:

The gut microbiome as a modulator of healthy ageing
Tarini Shankar Ghosh, Fergus Shanahan, Paul W. O’Toole
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 9, pp. 565-584
Open Access | Times Cited: 421
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders
Shokufeh Ghasemian Sorboni, Hanieh Shakeri Moghaddam, Reza Jafarzadeh Esfehani, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 1
Open Access | Times Cited: 307
Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies
Yuting Lu, Xiangliang Yuan, Miao Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 266
Partners in Leaky Gut Syndrome: Intestinal Dysbiosis and Autoimmunity
Yusuke Kinashi, Koji Hase
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 246
Butyrate producers, “The Sentinel of Gut”: Their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics
Vineet Singh, GyuDae Lee, HyunWoo Son, et al.
Frontiers in Microbiology (2023) Vol. 13
Open Access | Times Cited: 241
Polyphenols—Gut Microbiota Interrelationship: A Transition to a New Generation of Prebiotics
Diana Plamada, Dan Cristian Vodnar
Nutrients (2021) Vol. 14, Iss. 1, pp. 137-137
Open Access | Times Cited: 220
Engineering living therapeutics with synthetic biology
Andrés Cubillos-Ruiz, Tingxi Guo, Anna Sokolovska, et al.
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 12, pp. 941-960
Closed Access | Times Cited: 213
Understanding the gut microbiota and sarcopenia: a systematic review
Chaoran Liu, Wing‐Hoi Cheung, Jie Li, et al.
Journal of Cachexia Sarcopenia and Muscle (2021) Vol. 12, Iss. 6, pp. 1393-1407
Open Access | Times Cited: 209
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Jian Sheng Loh, Wen Qi Mak, Li Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 202
Microbiota medicine: towards clinical revolution
Prisca Gebrayel, Carole Nicco, Souhaila Al Khodor, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 192
From gut microbiota to host appetite: gut microbiota-derived metabolites as key regulators
Hui Han, Bao Yi, Ruqing Zhong, et al.
Microbiome (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 187
Gut microbiota-derived short chain fatty acids are potential mediators in gut inflammation
Muhammad Faheem Akhtar, Yan Chen, Ziyu Ma, et al.
Animal nutrition (2021) Vol. 8, pp. 350-360
Open Access | Times Cited: 166
Advancing human gut microbiota research by considering gut transit time
Nicola Procházková, Gwen Falony, Lars Ove Dragsted, et al.
Gut (2022) Vol. 72, Iss. 1, pp. 180-191
Open Access | Times Cited: 158
Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions
Bin Wang, Lei Zhang, Yongqiang Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 153
Metabolites as signalling molecules
Steven Andrew Baker, Jared Rutter
Nature Reviews Molecular Cell Biology (2023) Vol. 24, Iss. 5, pp. 355-374
Closed Access | Times Cited: 153
The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases
Farideh Hosseinkhani, Almut Heinken, Ines Thiele, et al.
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 145
Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications
Lin-Yong Zhao, Jia-Xin Mei, Gang Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 145
MetOrigin: Discriminating the origins of microbial metabolites for integrative analysis of the gut microbiome and metabolome
Gang Yu, Cuifang Xu, Danni Zhang, et al.
iMeta (2022) Vol. 1, Iss. 1
Open Access | Times Cited: 142
Ruminococcus gnavus: friend or foe for human health
Emmanuelle H. Crost, Erika Coletto, Andrew Bell, et al.
FEMS Microbiology Reviews (2023) Vol. 47, Iss. 2
Open Access | Times Cited: 140
Multimodal interactions of drugs, natural compounds and pollutants with the gut microbiota
Anna E. Lindell, Maria Zimmermann‐Kogadeeva, Kiran Raosaheb Patil
Nature Reviews Microbiology (2022) Vol. 20, Iss. 7, pp. 431-443
Open Access | Times Cited: 133
Microbiome-derived ethanol in nonalcoholic fatty liver disease
Abraham S. Meijnikman, Mark Davids, Hilde Herrema, et al.
Nature Medicine (2022) Vol. 28, Iss. 10, pp. 2100-2106
Closed Access | Times Cited: 129
Cross-feeding in the gut microbiome: Ecology and mechanisms
Elizabeth J. Culp, Andrew L. Goodman
Cell Host & Microbe (2023) Vol. 31, Iss. 4, pp. 485-499
Open Access | Times Cited: 125
Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia
Emily Connell, Gwénaëlle Le Gall, Matthew G. Pontifex, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 121
Gut microbes and muscle function: can probiotics make our muscles stronger?
Muriel Giron, Muriel Thomas, Dominique Dardevet, et al.
Journal of Cachexia Sarcopenia and Muscle (2022) Vol. 13, Iss. 3, pp. 1460-1476
Open Access | Times Cited: 114
Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome
Lin Xiao, Qin Liu, Mei Luo, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 105
Page 1 - Next Page

Scroll to top